research use only
Cat.No.: F4647
| Dilution |
|---|
|
| Application |
|---|
| WB |
| Reactivity |
|---|
| Human |
| Source |
|---|
| Rabbit Monoclonal Antibody |
| Storage Buffer |
|---|
| PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3 |
| Storage (from the date of receipt) |
|---|
| -20°C (avoid freeze-thaw cycles), 2 years |
| Predicted MW |
|---|
| 115-130 kDa |
| Positive Control | HT-29 cells (pIpC, 100 μg/ml, overnight) |
|---|---|
| Negative Control |
| WB |
|---|
Experimental Protocol:
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature. 2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min. 3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min. 4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations 2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip"; 4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications Recommended conditions for wet transfer: 200 mA, 120 min. ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight; 2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system. |
| Specificity |
|---|
| Toll-like Receptor 3 Antibody [H22B16] detects endogenous levels of total Toll-like Receptor 3 protein. |
| Subcellular Location |
|---|
| Endoplasmic reticulum, Endosome, Membrane |
| Uniprot ID |
|---|
| O15455 |
| Clone |
|---|
| H22B16 |
| Synonym |
|---|
| Toll-like receptor 3; CD283; TLR3 |
| Background |
|---|
| Toll-like receptor 3 (TLR3) is a key endosomal pattern recognition receptor (PRR) predominantly expressed in dendritic cells, fibroblasts, and epithelial cells, specializing in the recognition of double-stranded RNA (dsRNA) and synthetic analogs like poly(I:C) to initiate antiviral immunity. TLR3 consists of 23 extracellular leucine-rich repeats (LRRs) forming a glycosylated horseshoe-shaped ectodomain with lateral ligand-binding sites lacking glycan shielding, which facilitates dimeric dsRNA engagement, alongside a single transmembrane helix and a cytoplasmic Toll/IL-1 receptor (TIR) domain containing conserved BB-loop motifs critical for TRIF adaptor recruitment. Upon ligand binding, TLR3 dimerizes, enabling TIR-TRIF interaction via BB-loop docking and assembling a TRAF6/RIP1/14-3-3ζ signalosome that bifurcates into two major pathways: NF-κB activation through TAK1/IKKβ-mediated IκBα degradation, which drives proinflammatory cytokines (IL-6, TNF-α, IL-12), and IRF3/7 phosphorylation via TBK1/IKKε for type I interferon (IFN-α/β) induction. TRIF’s N-terminal domain also engages FADD/caspase-8, integrating apoptotic regulation. Lysosomal acidification and UNC93B1-mediated trafficking strictly control TLR3’s localization and activation, with rapid endocytosis curbing potential overactivation. Dysregulation of TLR3 contributes to autoimmune diseases such as SLE (via apoptotic RNA recognition), chronic inflammation in conditions like psoriasis and COPD, and context-dependent tumor progression, where poly(I:C) can induce either immunogenic cell death or chemoresistance. |
| References |
|---|
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.